Among the different chemotherapeutics used to treat colorectal cancer, 5-fluorouracil (5-FU), a pyrimidine analog that acts as a thymidylate synthase (TS) inhibitor, is a first-line drug due to its low price and effective anticancer activity [2,3]. This evidence concerns the gene TYMS and colorectal cancer.